Highbridge Capital Management LLC Madrigal Pharmaceuticals, Inc. Transaction History

Highbridge Capital Management LLC

  • $333 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$91.13 - $142.5 $911,300 - $1.43 Million
-10,000 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$103.48 - $143.84 $388,050 - $539,400
-3,750 Reduced 27.27%
10,000 $1.25 Million
Q4 2018

Feb 14, 2019
BUY
$94.77 - $215.54 $355,387 - $808,275
3,750 Added 37.5%
13,750 $1.55 Million
Q3 2018

Nov 13, 2018
BUY
$207.3 - $300.31 $2.07 Million - $3 Million
10,000 New
10,000 $2.14 Million

Others Institutions Holding MDGL

# of Institutions
297
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.34B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Highbridge Capital Management LLC Portfolio

Follow Highbridge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highbridge Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email